The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Insulin Needle-free Syringes Market Research Report 2025

Global Insulin Needle-free Syringes Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1983159

No of Pages : 89

Ask Your Query
Synopsis
Needle-free nozzle is the key feature of the system. By pressing insulin through the nozzle orifice, a fine stream of insulin is created that easily penetrates the skin. Subsequently, the insulin follows the path of least resistance, spreading evenly in the subcutaneous layer.
The global Insulin Needle-free Syringes market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Insulin Needle-free Syringes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Insulin Needle-free Syringes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Insulin Needle-free Syringes include Zogenix, Inovio, Glide Pharma, Akra Dermojet, Crossject Medical Technology, Injex Pharma, Eternity Healthcare, Antares Pharma and Valeritas, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Insulin Needle-free Syringes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Needle-free Syringes.
Report Scope
The Insulin Needle-free Syringes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Insulin Needle-free Syringes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Needle-free Syringes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zogenix
Inovio
Glide Pharma
Akra Dermojet
Crossject Medical Technology
Injex Pharma
Eternity Healthcare
Antares Pharma
Valeritas
Medical International Technologies
Penjet
PharmaJet
National Medical Products
Activa Brand Products
Segment by Type
Powder Injections
Liquid Injections
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Needle-free Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Needle-free Syringes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Insulin Needle-free Syringes Market Overview
1.1 Product Overview and Scope of Insulin Needle-free Syringes
1.2 Insulin Needle-free Syringes Segment by Type
1.2.1 Global Insulin Needle-free Syringes Market Value Comparison by Type (2024-2030)
1.2.2 Powder Injections
1.2.3 Liquid Injections
1.3 Insulin Needle-free Syringes Segment by Application
1.3.1 Global Insulin Needle-free Syringes Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Insulin Needle-free Syringes Market Size Estimates and Forecasts
1.4.1 Global Insulin Needle-free Syringes Revenue 2019-2030
1.4.2 Global Insulin Needle-free Syringes Sales 2019-2030
1.4.3 Global Insulin Needle-free Syringes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Needle-free Syringes Market Competition by Manufacturers
2.1 Global Insulin Needle-free Syringes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Needle-free Syringes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Needle-free Syringes Average Price by Manufacturers (2019-2024)
2.4 Global Insulin Needle-free Syringes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Needle-free Syringes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Needle-free Syringes, Product Type & Application
2.7 Insulin Needle-free Syringes Market Competitive Situation and Trends
2.7.1 Insulin Needle-free Syringes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insulin Needle-free Syringes Players Market Share by Revenue
2.7.3 Global Insulin Needle-free Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insulin Needle-free Syringes Retrospective Market Scenario by Region
3.1 Global Insulin Needle-free Syringes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Needle-free Syringes Global Insulin Needle-free Syringes Sales by Region: 2019-2030
3.2.1 Global Insulin Needle-free Syringes Sales by Region: 2019-2024
3.2.2 Global Insulin Needle-free Syringes Sales by Region: 2025-2030
3.3 Global Insulin Needle-free Syringes Global Insulin Needle-free Syringes Revenue by Region: 2019-2030
3.3.1 Global Insulin Needle-free Syringes Revenue by Region: 2019-2024
3.3.2 Global Insulin Needle-free Syringes Revenue by Region: 2025-2030
3.4 North America Insulin Needle-free Syringes Market Facts & Figures by Country
3.4.1 North America Insulin Needle-free Syringes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Needle-free Syringes Sales by Country (2019-2030)
3.4.3 North America Insulin Needle-free Syringes Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Needle-free Syringes Market Facts & Figures by Country
3.5.1 Europe Insulin Needle-free Syringes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Needle-free Syringes Sales by Country (2019-2030)
3.5.3 Europe Insulin Needle-free Syringes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Needle-free Syringes Market Facts & Figures by Country
3.6.1 Asia Pacific Insulin Needle-free Syringes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Needle-free Syringes Sales by Country (2019-2030)
3.6.3 Asia Pacific Insulin Needle-free Syringes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Needle-free Syringes Market Facts & Figures by Country
3.7.1 Latin America Insulin Needle-free Syringes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Needle-free Syringes Sales by Country (2019-2030)
3.7.3 Latin America Insulin Needle-free Syringes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Needle-free Syringes Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Needle-free Syringes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Needle-free Syringes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Needle-free Syringes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Needle-free Syringes Sales by Type (2019-2030)
4.1.1 Global Insulin Needle-free Syringes Sales by Type (2019-2024)
4.1.2 Global Insulin Needle-free Syringes Sales by Type (2025-2030)
4.1.3 Global Insulin Needle-free Syringes Sales Market Share by Type (2019-2030)
4.2 Global Insulin Needle-free Syringes Revenue by Type (2019-2030)
4.2.1 Global Insulin Needle-free Syringes Revenue by Type (2019-2024)
4.2.2 Global Insulin Needle-free Syringes Revenue by Type (2025-2030)
4.2.3 Global Insulin Needle-free Syringes Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Needle-free Syringes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Needle-free Syringes Sales by Application (2019-2030)
5.1.1 Global Insulin Needle-free Syringes Sales by Application (2019-2024)
5.1.2 Global Insulin Needle-free Syringes Sales by Application (2025-2030)
5.1.3 Global Insulin Needle-free Syringes Sales Market Share by Application (2019-2030)
5.2 Global Insulin Needle-free Syringes Revenue by Application (2019-2030)
5.2.1 Global Insulin Needle-free Syringes Revenue by Application (2019-2024)
5.2.2 Global Insulin Needle-free Syringes Revenue by Application (2025-2030)
5.2.3 Global Insulin Needle-free Syringes Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Needle-free Syringes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zogenix
6.1.1 Zogenix Corporation Information
6.1.2 Zogenix Description and Business Overview
6.1.3 Zogenix Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zogenix Insulin Needle-free Syringes Product Portfolio
6.1.5 Zogenix Recent Developments/Updates
6.2 Inovio
6.2.1 Inovio Corporation Information
6.2.2 Inovio Description and Business Overview
6.2.3 Inovio Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Inovio Insulin Needle-free Syringes Product Portfolio
6.2.5 Inovio Recent Developments/Updates
6.3 Glide Pharma
6.3.1 Glide Pharma Corporation Information
6.3.2 Glide Pharma Description and Business Overview
6.3.3 Glide Pharma Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glide Pharma Insulin Needle-free Syringes Product Portfolio
6.3.5 Glide Pharma Recent Developments/Updates
6.4 Akra Dermojet
6.4.1 Akra Dermojet Corporation Information
6.4.2 Akra Dermojet Description and Business Overview
6.4.3 Akra Dermojet Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Akra Dermojet Insulin Needle-free Syringes Product Portfolio
6.4.5 Akra Dermojet Recent Developments/Updates
6.5 Crossject Medical Technology
6.5.1 Crossject Medical Technology Corporation Information
6.5.2 Crossject Medical Technology Description and Business Overview
6.5.3 Crossject Medical Technology Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Crossject Medical Technology Insulin Needle-free Syringes Product Portfolio
6.5.5 Crossject Medical Technology Recent Developments/Updates
6.6 Injex Pharma
6.6.1 Injex Pharma Corporation Information
6.6.2 Injex Pharma Description and Business Overview
6.6.3 Injex Pharma Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Injex Pharma Insulin Needle-free Syringes Product Portfolio
6.6.5 Injex Pharma Recent Developments/Updates
6.7 Eternity Healthcare
6.6.1 Eternity Healthcare Corporation Information
6.6.2 Eternity Healthcare Description and Business Overview
6.6.3 Eternity Healthcare Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eternity Healthcare Insulin Needle-free Syringes Product Portfolio
6.7.5 Eternity Healthcare Recent Developments/Updates
6.8 Antares Pharma
6.8.1 Antares Pharma Corporation Information
6.8.2 Antares Pharma Description and Business Overview
6.8.3 Antares Pharma Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Antares Pharma Insulin Needle-free Syringes Product Portfolio
6.8.5 Antares Pharma Recent Developments/Updates
6.9 Valeritas
6.9.1 Valeritas Corporation Information
6.9.2 Valeritas Description and Business Overview
6.9.3 Valeritas Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Valeritas Insulin Needle-free Syringes Product Portfolio
6.9.5 Valeritas Recent Developments/Updates
6.10 Medical International Technologies
6.10.1 Medical International Technologies Corporation Information
6.10.2 Medical International Technologies Description and Business Overview
6.10.3 Medical International Technologies Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medical International Technologies Insulin Needle-free Syringes Product Portfolio
6.10.5 Medical International Technologies Recent Developments/Updates
6.11 Penjet
6.11.1 Penjet Corporation Information
6.11.2 Penjet Insulin Needle-free Syringes Description and Business Overview
6.11.3 Penjet Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Penjet Insulin Needle-free Syringes Product Portfolio
6.11.5 Penjet Recent Developments/Updates
6.12 PharmaJet
6.12.1 PharmaJet Corporation Information
6.12.2 PharmaJet Insulin Needle-free Syringes Description and Business Overview
6.12.3 PharmaJet Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.12.4 PharmaJet Insulin Needle-free Syringes Product Portfolio
6.12.5 PharmaJet Recent Developments/Updates
6.13 National Medical Products
6.13.1 National Medical Products Corporation Information
6.13.2 National Medical Products Insulin Needle-free Syringes Description and Business Overview
6.13.3 National Medical Products Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.13.4 National Medical Products Insulin Needle-free Syringes Product Portfolio
6.13.5 National Medical Products Recent Developments/Updates
6.14 Activa Brand Products
6.14.1 Activa Brand Products Corporation Information
6.14.2 Activa Brand Products Insulin Needle-free Syringes Description and Business Overview
6.14.3 Activa Brand Products Insulin Needle-free Syringes Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Activa Brand Products Insulin Needle-free Syringes Product Portfolio
6.14.5 Activa Brand Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Needle-free Syringes Industry Chain Analysis
7.2 Insulin Needle-free Syringes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Needle-free Syringes Production Mode & Process
7.4 Insulin Needle-free Syringes Sales and Marketing
7.4.1 Insulin Needle-free Syringes Sales Channels
7.4.2 Insulin Needle-free Syringes Distributors
7.5 Insulin Needle-free Syringes Customers
8 Insulin Needle-free Syringes Market Dynamics
8.1 Insulin Needle-free Syringes Industry Trends
8.2 Insulin Needle-free Syringes Market Drivers
8.3 Insulin Needle-free Syringes Market Challenges
8.4 Insulin Needle-free Syringes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Insulin Needle-free Syringes Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Insulin Needle-free Syringes Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Insulin Needle-free Syringes Market Competitive Situation by Manufacturers in 2023
Table 4. Global Insulin Needle-free Syringes Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Insulin Needle-free Syringes Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Insulin Needle-free Syringes Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Insulin Needle-free Syringes Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Insulin Needle-free Syringes Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Insulin Needle-free Syringes, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Needle-free Syringes, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Needle-free Syringes, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Needle-free Syringes, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Needle-free Syringes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Needle-free Syringes as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Needle-free Syringes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Insulin Needle-free Syringes Sales by Region (2019-2024) & (K Units)
Table 18. Global Insulin Needle-free Syringes Sales Market Share by Region (2019-2024)
Table 19. Global Insulin Needle-free Syringes Sales by Region (2025-2030) & (K Units)
Table 20. Global Insulin Needle-free Syringes Sales Market Share by Region (2025-2030)
Table 21. Global Insulin Needle-free Syringes Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Insulin Needle-free Syringes Revenue Market Share by Region (2019-2024)
Table 23. Global Insulin Needle-free Syringes Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Insulin Needle-free Syringes Revenue Market Share by Region (2025-2030)
Table 25. North America Insulin Needle-free Syringes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Insulin Needle-free Syringes Sales by Country (2019-2024) & (K Units)
Table 27. North America Insulin Needle-free Syringes Sales by Country (2025-2030) & (K Units)
Table 28. North America Insulin Needle-free Syringes Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Insulin Needle-free Syringes Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Insulin Needle-free Syringes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Insulin Needle-free Syringes Sales by Country (2019-2024) & (K Units)
Table 32. Europe Insulin Needle-free Syringes Sales by Country (2025-2030) & (K Units)
Table 33. Europe Insulin Needle-free Syringes Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Insulin Needle-free Syringes Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Insulin Needle-free Syringes Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Insulin Needle-free Syringes Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Insulin Needle-free Syringes Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Insulin Needle-free Syringes Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Insulin Needle-free Syringes Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insulin Needle-free Syringes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Insulin Needle-free Syringes Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Insulin Needle-free Syringes Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Insulin Needle-free Syringes Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Insulin Needle-free Syringes Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Insulin Needle-free Syringes Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Insulin Needle-free Syringes Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Insulin Needle-free Syringes Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Insulin Needle-free Syringes Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Insulin Needle-free Syringes Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Insulin Needle-free Syringes Sales (K Units) by Type (2019-2024)
Table 51. Global Insulin Needle-free Syringes Sales (K Units) by Type (2025-2030)
Table 52. Global Insulin Needle-free Syringes Sales Market Share by Type (2019-2024)
Table 53. Global Insulin Needle-free Syringes Sales Market Share by Type (2025-2030)
Table 54. Global Insulin Needle-free Syringes Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Insulin Needle-free Syringes Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Insulin Needle-free Syringes Revenue Market Share by Type (2019-2024)
Table 57. Global Insulin Needle-free Syringes Revenue Market Share by Type (2025-2030)
Table 58. Global Insulin Needle-free Syringes Price (USD/Unit) by Type (2019-2024)
Table 59. Global Insulin Needle-free Syringes Price (USD/Unit) by Type (2025-2030)
Table 60. Global Insulin Needle-free Syringes Sales (K Units) by Application (2019-2024)
Table 61. Global Insulin Needle-free Syringes Sales (K Units) by Application (2025-2030)
Table 62. Global Insulin Needle-free Syringes Sales Market Share by Application (2019-2024)
Table 63. Global Insulin Needle-free Syringes Sales Market Share by Application (2025-2030)
Table 64. Global Insulin Needle-free Syringes Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Insulin Needle-free Syringes Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Insulin Needle-free Syringes Revenue Market Share by Application (2019-2024)
Table 67. Global Insulin Needle-free Syringes Revenue Market Share by Application (2025-2030)
Table 68. Global Insulin Needle-free Syringes Price (USD/Unit) by Application (2019-2024)
Table 69. Global Insulin Needle-free Syringes Price (USD/Unit) by Application (2025-2030)
Table 70. Zogenix Corporation Information
Table 71. Zogenix Description and Business Overview
Table 72. Zogenix Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Zogenix Insulin Needle-free Syringes Product
Table 74. Zogenix Recent Developments/Updates
Table 75. Inovio Corporation Information
Table 76. Inovio Description and Business Overview
Table 77. Inovio Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Inovio Insulin Needle-free Syringes Product
Table 79. Inovio Recent Developments/Updates
Table 80. Glide Pharma Corporation Information
Table 81. Glide Pharma Description and Business Overview
Table 82. Glide Pharma Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Glide Pharma Insulin Needle-free Syringes Product
Table 84. Glide Pharma Recent Developments/Updates
Table 85. Akra Dermojet Corporation Information
Table 86. Akra Dermojet Description and Business Overview
Table 87. Akra Dermojet Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Akra Dermojet Insulin Needle-free Syringes Product
Table 89. Akra Dermojet Recent Developments/Updates
Table 90. Crossject Medical Technology Corporation Information
Table 91. Crossject Medical Technology Description and Business Overview
Table 92. Crossject Medical Technology Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Crossject Medical Technology Insulin Needle-free Syringes Product
Table 94. Crossject Medical Technology Recent Developments/Updates
Table 95. Injex Pharma Corporation Information
Table 96. Injex Pharma Description and Business Overview
Table 97. Injex Pharma Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Injex Pharma Insulin Needle-free Syringes Product
Table 99. Injex Pharma Recent Developments/Updates
Table 100. Eternity Healthcare Corporation Information
Table 101. Eternity Healthcare Description and Business Overview
Table 102. Eternity Healthcare Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Eternity Healthcare Insulin Needle-free Syringes Product
Table 104. Eternity Healthcare Recent Developments/Updates
Table 105. Antares Pharma Corporation Information
Table 106. Antares Pharma Description and Business Overview
Table 107. Antares Pharma Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Antares Pharma Insulin Needle-free Syringes Product
Table 109. Antares Pharma Recent Developments/Updates
Table 110. Valeritas Corporation Information
Table 111. Valeritas Description and Business Overview
Table 112. Valeritas Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Valeritas Insulin Needle-free Syringes Product
Table 114. Valeritas Recent Developments/Updates
Table 115. Medical International Technologies Corporation Information
Table 116. Medical International Technologies Description and Business Overview
Table 117. Medical International Technologies Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Medical International Technologies Insulin Needle-free Syringes Product
Table 119. Medical International Technologies Recent Developments/Updates
Table 120. Penjet Corporation Information
Table 121. Penjet Description and Business Overview
Table 122. Penjet Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Penjet Insulin Needle-free Syringes Product
Table 124. Penjet Recent Developments/Updates
Table 125. PharmaJet Corporation Information
Table 126. PharmaJet Description and Business Overview
Table 127. PharmaJet Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. PharmaJet Insulin Needle-free Syringes Product
Table 129. PharmaJet Recent Developments/Updates
Table 130. National Medical Products Corporation Information
Table 131. National Medical Products Description and Business Overview
Table 132. National Medical Products Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. National Medical Products Insulin Needle-free Syringes Product
Table 134. National Medical Products Recent Developments/Updates
Table 135. Activa Brand Products Corporation Information
Table 136. Activa Brand Products Description and Business Overview
Table 137. Activa Brand Products Insulin Needle-free Syringes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Activa Brand Products Insulin Needle-free Syringes Product
Table 139. Activa Brand Products Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Insulin Needle-free Syringes Distributors List
Table 143. Insulin Needle-free Syringes Customers List
Table 144. Insulin Needle-free Syringes Market Trends
Table 145. Insulin Needle-free Syringes Market Drivers
Table 146. Insulin Needle-free Syringes Market Challenges
Table 147. Insulin Needle-free Syringes Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Needle-free Syringes
Figure 2. Global Insulin Needle-free Syringes Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Insulin Needle-free Syringes Market Share by Type in 2023 & 2030
Figure 4. Powder Injections Product Picture
Figure 5. Liquid Injections Product Picture
Figure 6. Global Insulin Needle-free Syringes Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Insulin Needle-free Syringes Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Insulin Needle-free Syringes Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Insulin Needle-free Syringes Market Size (2019-2030) & (US$ Million)
Figure 13. Global Insulin Needle-free Syringes Sales (2019-2030) & (K Units)
Figure 14. Global Insulin Needle-free Syringes Average Price (USD/Unit) & (2019-2030)
Figure 15. Insulin Needle-free Syringes Report Years Considered
Figure 16. Insulin Needle-free Syringes Sales Share by Manufacturers in 2023
Figure 17. Global Insulin Needle-free Syringes Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Insulin Needle-free Syringes Players: Market Share by Revenue in 2023
Figure 19. Insulin Needle-free Syringes Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Insulin Needle-free Syringes Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Insulin Needle-free Syringes Sales Market Share by Country (2019-2030)
Figure 22. North America Insulin Needle-free Syringes Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Insulin Needle-free Syringes Sales Market Share by Country (2019-2030)
Figure 26. Europe Insulin Needle-free Syringes Revenue Market Share by Country (2019-2030)
Figure 27. Germany Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Insulin Needle-free Syringes Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Insulin Needle-free Syringes Revenue Market Share by Region (2019-2030)
Figure 34. China Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Insulin Needle-free Syringes Sales Market Share by Country (2019-2030)
Figure 45. Latin America Insulin Needle-free Syringes Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Insulin Needle-free Syringes Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Insulin Needle-free Syringes Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Insulin Needle-free Syringes Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Insulin Needle-free Syringes by Type (2019-2030)
Figure 55. Global Revenue Market Share of Insulin Needle-free Syringes by Type (2019-2030)
Figure 56. Global Insulin Needle-free Syringes Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Insulin Needle-free Syringes by Application (2019-2030)
Figure 58. Global Revenue Market Share of Insulin Needle-free Syringes by Application (2019-2030)
Figure 59. Global Insulin Needle-free Syringes Price (USD/Unit) by Application (2019-2030)
Figure 60. Insulin Needle-free Syringes Value Chain
Figure 61. Insulin Needle-free Syringes Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock